Pharmacokinetics, Pharmacodynamics and Clinical Use of SGLT2 Inhibitors in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease
Crossref DOI link: https://doi.org/10.1007/s40262-015-0264-4
Published Online: 2015-03-25
Published Print: 2015-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Scheen, André J.
Text and Data Mining valid from 2015-03-25